A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain
NCT02989792 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2019-05-08
Summary
Patients having completed former trials T1001-01 or T1001-02 will undergo one blood sampling for genotyping purposes. In addition they will compete the personality questionnaires they had completed in the former trial.
Conditions
Interventions
- GENETIC
-
Blood sampling for genotyping
Venous punction of maximum 10 millilitres
- OTHER
-
Personality Questionnaires completion
Completion of the following questionnaires: Multidimensional Personality Questionnaire (MPSQ), Interpersonal Reactivity Index (IRI) and Behavioral inhibition system/ Behavioral activation systems (BISBAS) questionnaires
Sponsors & Collaborators
-
Tools4Patient
lead OTHER
Principal Investigators
-
Alvaro Pereira · Tools4Patient
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-08
- Primary Completion
- 2017-10-05
- Completion
- 2017-10-05
Countries
- Belgium
- France
Study Locations
More Related Trials
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
NCT05986292 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
NCT01087203 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
NCT01053845 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107 ·Status: TERMINATED ·Phase: NA
-
Analysis of Markers in the Blood Correlated With Neuropathic Pain
NCT02208206 ·Status: COMPLETED
-
Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)
NCT04184596 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain
NCT05838755 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
NCT06858579 ·Status: RECRUITING ·Phase: PHASE3
-
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
NCT00385671 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain
NCT01579279 ·Status: TERMINATED ·Phase: PHASE2
-
Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
NCT00619983 ·Status: TERMINATED ·Phase: PHASE4
-
Study of DA-9801 to Treat Diabetic Neuropathic Pain
NCT01813799 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Pain Associated With Fibromyalgia
NCT02146430 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects
NCT02116790 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
NCT00507936 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain
NCT04529096 ·Status: COMPLETED ·Phase: PHASE2
-
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).
NCT05620576 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients
NCT02215798 ·Status: COMPLETED
-
A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
NCT01820715 ·Status: COMPLETED ·Phase: PHASE1
-
Dorsal Root Ganglion Stimulation in Postherpetic Neuropathy
NCT06225960 ·Status: COMPLETED
-
Study of Mirogabalin for Central Neuropathic Pain
NCT03901352 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Painful Diabetic Neuropathy
NCT01089556 ·Status: COMPLETED ·Phase: PHASE3
-
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294 ·Status: UNKNOWN
-
A Study of Tanezumab in Adults With Chronic Low Back Pain
NCT00876187 ·Status: COMPLETED ·Phase: PHASE2